logo-loader

IXICO PLC secures significant new contracts with two new clients

Published: 19:47 24 Apr 2019 AEST

IXICO PLC's (LON:IXI) John Hall came into Proactive London to discuss two significant new contracts they've agreed with new biopharmaceutical clients.

The first contract, to support an early phase study into Huntington’s Disease (HD), is worth around £2mln and will be delivered over seven years.

The other's for a Phase 3 study for another rare neurological disease.

Australian Strategic Materials signs US$600 million LoI

Rowena Smith, CEO and managing director of Australian Strategic Materials Ltd (ASX:ASM, OTC:ASMMF), joins Jonathan Jackson in the Proactive studio to discuss the company’ s Dubbo Project, in Central West New South Wales. This project aims to extract and process critical minerals and rare earth...

9 hours, 16 minutes ago